Icodextrin to delay full-dose dialysis in first year of incremental PD
Part of Kidney & urinary clinical trials.
This study tests whether a special dialysis fluid called icodextrin can help people on a low-dose form of peritoneal dialysis stay on that low dose longer before needing a full dose. It is for adults who still make some urine and can do dialysis at home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- Your kidney function (eGFR) is at least 3 when the study starts.
- You still make at least 500 ml (about 2 cups) of urine per day.
- You are able to learn and do home peritoneal dialysis with a helper if needed.
- You can come to the clinic for checkups every 2 months or so for at least 13 months.
- You are not allergic to icodextrin, starch, or starch products, and do not have glycogen storage disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special dialysis fluid made with amino acids (protein building blocks) instead of the usual sugar-based fluid. It may help control blood sugar and improve nutrition in people with diabetes on peritoneal dialysis.
This study tests whether continuous glucose monitors (CGMs) work accurately in people doing peritoneal dialysis with icodextrin solution. It may help you manage your diabetes better by showing your glucose levels in real time.
This trial tests whether empagliflozin, a medication originally for diabetes, can help protect the remaining kidney function in people who have just started peritoneal dialysis. If you started dialysis within the last 3 months and still make some urine, this study may be a good fit.
This study tests whether using a continuous glucose monitor (a small sensor that checks blood sugar levels throughout the day) can help improve diabetes control in people who are on peritoneal dialysis (a type of kidney dialysis done at home). It aims to see if this technology leads to better health outcomes.
This trial tests a way of doing peritoneal dialysis (a type of home dialysis for kidney failure) that uses a special fluid called icodextrin once a day. It aims to see if this approach is safe and works well for people who are just starting dialysis and still pass urine.
This study tests whether using two evening dialysis fluid bags (with a special fluid called icodextrin) can help control blood pressure better than the usual one bag. This might be helpful for children who have high blood pressure and low urine output while on peritoneal dialysis.
Hear when a new Peritoneal Dialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.